Sep 26, 2019 - Sanofi's (SNY) stock is on an upward trajectory this year. Let us have a look at the reasons for the same.
Sep 27, 2019 - AbbVie (ABBV) gets FDA approval for the label expansion of Mavyret.
Oct 01, 2019 - Immunomedics (IMMU) presents interim data on sacituzumab govitecan in patients with metastatic urothelial cancer. The company also inks two deals.
Oct 02, 2019 - AstraZeneca (AZN) gets CRL from the FDA for PT010, its triple-combo inhaler to treat COPD.
Oct 04, 2019 - J&J (JNJ) settles with two Ohio plaintiffs for $10 million. FDA updates for AstraZeneca (AZN), Merck (MRK) and others and ESMO presentations by big pharma companies in focus.
Oct 04, 2019 - Gilead (GILD) obtains FDA approval for HIV treatment Descovy as a prevention option.
Oct 07, 2019 - Top Analyst Reports for General Dynamics, Merck & Progressive
Oct 18, 2019 - Despite severe market volatility, the Dow is still in positive territory with a gain of 15.9% year to date. This is an excellent performance after a disappointing 2018.
Oct 18, 2019 - Investors will focus on regular top and bottom-line numbers along with pipeline updates, when Novartis (NVS) reports third-quarter 2019 results.
Oct 21, 2019 - With earnings surprise in the cards, the healthcare sector is expected to witness modest earnings growth of 0.3% in the third quarter, suggesting some room for potential upside for healthcare ETFs.